iRhythm Holdings, Inc. (LON:0A7L)
London · Delayed Price · Currency is GBP · Price in USD | Market Cap | 2.75B -33.9% |
| Revenue (ttm) | 622.06M +25.6% |
| Net Income | -10.51M |
| EPS | -0.32 |
| Shares Out | n/a |
| PE Ratio | n/a |
| Forward PE | 161.30 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 3 |
| Open | 113.54 |
| Previous Close | 111.33 |
| Day's Range | 109.75 - 113.54 |
| 52-Week Range | 97.71 - 206.00 |
| Beta | 1.32 |
| Analysts | n/a |
| Price Target | n/a |
| Est. Earnings | Nov 5, 2026 |
About iRhythm Holdings
iRhythm Holdings, Inc., a digital healthcare company, engages in the design, development, and commercialization of device-based technology that provides ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. The company offers Zio ambulatory cardiac monitoring services, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services. It also provides Zio Monitor System, a prescription-only remote electrocardiogram (ECG) monitoring system consisting a patch ECG monitor that ... [Read more]
Financial Performance
In 2025, iRhythm Holdings's revenue was $747.14 million, an increase of 26.24% compared to the previous year's $591.84 million. Losses were -$44.55 million, -60.67% less than in 2024.
Financial numbers in USD Financial StatementsNews
iRhythm Holdings Transcript: Wells Fargo 21st Annual Healthcare Conference
The acquisition of VitalConnect expands the product portfolio to fully address the MCT market, leveraging differentiated technology and a larger sales force for nationwide growth. Ambitions include reaching 30%-40% MCT market share, maintaining strong EBITDA margins, and driving innovation through EHR integration and multi-vitals capabilities.
iRhythm Holdings to Participate in Wells Fargo 21st Annual Healthcare Conference
SAN FRANCISCO, Aug. 26, 2026 (GLOBE NEWSWIRE) -- iRhythm Holdings, Inc. (NASDAQ: IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent di...
Did iRhythm Technologies, Inc. Insiders Breach their Fiduciary Duties to Shareholders?
Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be responsible...
iRhythm Holdings Earnings Call Transcript: Q2 2026
Q2 2026 saw 20%+ revenue growth, record profitability, and margin expansion, driven by strong demand and operational discipline. The VitalConnect acquisition will expand cardiac monitoring capabilities and address new market segments, with integration expected to accelerate growth from 2027.
iRhythm Holdings Earnings release: Q2 2026
iRhythm Holdings released its Q2 2026 earnings on August 6, 2026, summarizing the period's financial results.
iRhythm Holdings Slides: Q2 2026
iRhythm Holdings has posted slides in relation to its Q2 2026 quarterly earnings report, which was published on August 6, 2026.
iRhythm Holdings Quarterly report: Q2 2026
iRhythm Holdings has published its Q2 2026 quarterly earnings report on August 6, 2026.
iRhythm Holdings Announces Second Quarter 2026 Financial Results
SAN FRANCISCO, Aug. 06, 2026 (GLOBE NEWSWIRE) -- iRhythm Holdings, Inc. (NASDAQ: IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent di...
iRhythm Holdings to Report Second Quarter 2026 Financial Results on August 6, 2026
SAN FRANCISCO, July 16, 2026 (GLOBE NEWSWIRE) -- iRhythm Holdings, Inc. (NASDAQ: IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent di...
iRhythm Holdings Transcript: Truist Securities MedTech Conference 2026
A recent cybersecurity incident was contained without operational or financial impact, and regulatory timelines remain intact. Zio MCT's FDA submission is on track for a first half 2027 launch, with a new mobile gateway and significant AI-driven efficiency gains expected. Innovative channel partners are driving the fastest revenue growth, and regulatory remediation efforts are progressing.
iRhythm discloses cyber incident, says no impact on device systems, patient safety
iRhythm Holdings on Monday reported unauthorized activity involving data maintained on some third-party applications last week, but said it has not identified any impact on products, patient safety ...
iRhythm Holdings Transcript: 46th Annual William Blair Growth Stock Conference
Cardiac monitoring market share continues to grow, driven by product innovation, primary care expansion, and international opportunities. FDA clearance of a third-generation algorithm and strong Q1 financials support raised guidance and long-term margin goals.
iRhythm Holdings Slides: 46th Annual William Blair Growth Stock Conference
iRhythm Holdings has posted slides in relation to its latest quarterly earnings report, which was published on June 2, 2026.
iRhythm Holdings Transcript: AGM 2026
The meeting covered director elections, approval of the 2026 Equity Incentive Plan, amendments to governance documents, auditor ratification, and executive compensation. All proposals passed, and stockholder questions will be addressed post-meeting.
iRhythm Holdings to Participate in Upcoming Investor Conferences
SAN FRANCISCO, May 19, 2026 (GLOBE NEWSWIRE) -- iRhythm Holdings, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, prevent, and predict dise...
iRhythm Holdings Transcript: Bank of America Global Healthcare Conference 2026
LCD updates expanded patient access and Q1 delivered strong revenue and margin growth, led by Zio Monitor and innovative channels. AI-driven efficiencies and new product launches are expected to drive further margin gains, while international and innovative channel expansion remain key growth areas.
iRhythm Holdings Earnings Call Transcript: Q1 2026
Q1 2026 saw 25.7% revenue growth, margin expansion, and improved profitability, driven by strong volume across core and emerging channels. Guidance for 2026 was raised, with continued investment in AI, workflow integration, and international growth.
iRhythm Holdings Earnings release: Q1 2026
iRhythm Holdings released its Q1 2026 earnings on April 30, 2026, summarizing the period's financial results.
iRhythm Holdings Slides: Q1 2026
iRhythm Holdings has posted slides in relation to its Q1 2026 quarterly earnings report, which was published on April 30, 2026.
iRhythm Holdings Quarterly report: Q1 2026
iRhythm Holdings has published its Q1 2026 quarterly earnings report on April 30, 2026.
iRhythm Holdings Announces First Quarter 2026 Financial Results
SAN FRANCISCO, April 30, 2026 (GLOBE NEWSWIRE) -- iRhythm Holdings, Inc. (NASDAQ: IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent d...
iRhythm Holdings to Present at the Bank of America Securities 2026 Health Care Conference
SAN FRANCISCO, April 28, 2026 (GLOBE NEWSWIRE) -- iRhythm Holdings, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, prevent, and predict di...
New Data Presented at HRS 2026 Show Short-Term Holter Monitoring Misses a Large Proportion of AF Recurrence Post-Ablation and Clinically Significant Arrhythmias in Pregnancy
Real-world data presented at HRS 2026 add to the body of evidence supporting a shift away from short-duration Holter monitoring toward up to 14 days of continuous, uninterrupted monitoring with Zio ® ...
iRhythm Holdings Proxy statement: Proxy filing
iRhythm Holdings filed a proxy statement on April 17, 2026, providing details for shareholder voting and corporate governance matters.
iRhythm Holdings Proxy statement: Proxy filing
iRhythm Holdings filed a proxy statement on April 17, 2026, providing details for shareholder voting and corporate governance matters.